Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Study Says Future of AI In Healthcare Looks Very Optimistic

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Johnson & Johnson to Acquire Atraverse...

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough...

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in...

The U.S. Food and Drug Administration (FDA), through its...

It is well to be noted that 75% of healthcare professionals went on to anticipate the widespread implementation of AI in three years, i.e. by 2027 as per the new Berkeley Research Group study. This apparently looks to be quite a positive response for a technology that happens to be very new to healthcare.
What’s more is that 87% of the provider respondents happen to be confident in their organizations’ capacity to go ahead and comply with regulations that surround AI, the study points out. This is another unusually huge response to artificial intelligence.

The fact is that almost 60% of the provider respondents happen to be offering some form of internal training as well as education on AI, and 55% of them are indeed establishing AI-specific guidance on its appropriate use.
Although the healthcare sector has taken appropriate steps so as to self-regulate as a matter of necessity, there is still more that can be done.
As a matter of fact, only 37% of the provider respondents go on to indicate their organizations happen to be either reviewing or even planning to review regulatory guidance in order to make sure of proper AI execution.

Apparently, six out of every ten provider respondents go on to view the current AI regulations as well as guidance as offering adequate safety measures for the usage of AI. So, where does this kind of optimism come from?

Interestingly, 87% of the provider respondents happen to be confident in their organizations’ capacity to go ahead and comply with regulations, while at the same time indicating that HIPAA violations, precision, safety data privacy, and ethical standards continue to be priorities.

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Johnson & Johnson to Acquire Atraverse Medical Platform

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough Medical Device

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in Combination Products

The U.S. Food and Drug Administration (FDA), through its...

FDA 510(k) Clearance Granted to Philips Rembra Platform

Philips has secured FDA 510(k) clearance for its Rembra...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »